Genetic Inhibition of the Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated to F508del Cystic Fibrosis Mutation

Valeria Tomati, Elvira Sondo, Andrea Armirotti, Emanuela Caci, Emanuela Pesce, Monica Marini, Ambra Gianotti, Young Ju Jeon, Michele Cilli, Angela Pistorio, Luca Mastracci, Roberto Ravazzolo, Bob Scholte, Ze'ev Ronai, Luis J V Galietta, Nicoletta Pedemonte

Research output: Contribution to journalArticlepeer-review

Abstract

Cystic fibrosis (CF) is caused by mutations in the CFTR chloride channel. Deletion of phenylalanine 508 (F508del), the most frequent CF mutation, impairs CFTR trafficking and gating. F508del-CFTR mistrafficking may be corrected by acting directly on mutant CFTR itself or by modulating expression/activity of CFTR-interacting proteins, that may thus represent potential drug targets. To evaluate possible candidates for F508del-CFTR rescue, we screened a siRNA library targeting known CFTR interactors. Our analysis identified RNF5 as a protein whose inhibition promoted significant F508del-CFTR rescue and displayed an additive effect with the investigational drug VX-809. Significantly, RNF5 loss in F508del-CFTR transgenic animals ameliorated intestinal malabsorption and concomitantly led to an increase in CFTR activity in intestinal epithelial cells. In addition, we found that RNF5 is differentially expressed in human bronchial epithelia from CF vs. control patients. Our results identify RNF5 as a target for therapeutic modalities to antagonize mutant CFTR proteins.

Original languageEnglish
Article number12138
JournalScientific Reports
Volume5
DOIs
Publication statusPublished - Jul 17 2015

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Genetic Inhibition of the Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated to F508del Cystic Fibrosis Mutation'. Together they form a unique fingerprint.

Cite this